Clinical Trial Update: Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Pulmonary Vein Isolation alone versus Botulinum toxin injection plus Pulmonary Vein Isolation in patients with paroxysmal or pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation

Drugs mentioned

• Botulinum toxin type A (OnabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | Phase 2 | Status: UNKNOWN